FDA issued a Warning Letter to CTX Lifesciences Private Ltd. on 1/18/2017 as a result of this inspection.
483 CTX Lifesciences Private Feb 2016

483 CTX Lifesciences Private Feb 2016

Massoud Motamed FDA$119.00 - Available Now

FDA investigators audited the CTX Lifesciences Private - Surat, India facility and issued 6 inspectional observations (via FDA 483) on 19 Feb 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 6
  • Inspection end: 19 Feb 2016
  • Location: Surat, India
  • FEI: 3006254924
Add To Cart